Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BIOAF

biOasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders.
Price: $0.90 | Change: $-0.03 | %Change: -3.23%
Volume: 41,000 | Day High/Low: 0.95/0.90 | 52 Week High/Low: 1.35/0.67
View modes: 
0 stars

Stem Cells and Brain Cancer

Scientists from Harvard Medical School have discovered a way of turning stem cells into killing machines to fight brain cancer. An interesting article with no mention of the blood brain barrier or...read more
3 stars

RE:Biotech's hit record highs

Anonymous sold every share that traded today !!  rate and reply
3 stars

Biotech's hit record highs

Biotechs Hit Record High, +11.5% From Yellen's "Stretched Valuations" Warning   Submitted by Tyler Durden on 10/23/2014 10:20 -0400       ...read more
3.5 stars

BTI's ONE-TWO DATA PUNCH --> Lysosomal SD & BRAIN CANCER

The CEO said LSD was the perfect model to demonstrate the technology in the recent video. It involves just a single gene and if you can deliver the enzyme where it needs to go the read out is...read more
3.5 stars

RE:RE:RE:$1.50 coming quick!

i like when anon dumps and dumps observer....u know what that says...ill tell you...it says.." enough of the meddimune mumbo jumbo about  are very pleased...ands all that chit...how about you guys...read more
3 stars

RE:RE:$1.50 coming quick!

anonymous still dumping !!!  rate and reply
1 star

RE:$1.50 coming quick!

For coming quick, I recommend rubbing it before doing it.  rate and reply
1 star

RE:$1.50 coming quick!

Ya sir holler....1.50$ commin fast lol  rate and reply
2.5 stars

$1.50 coming quick!

They should get this cash on their balance sheet as quickly as possible in these uncertain times and given the risks in biotech. "Under the exercise acceleration clause, which the Company may...read more
3.5 stars

RE:Genervon BBB Competition?

I think they're more of a potential customer than a threat, minedigger. Of the several Master Regulator peptides they have discovered, the one they chose to move forward was GM6 (also named GM 604...read more
3 stars

Genervon BBB Competition?

Although BBB is not mentioned in the PR, does this peptide-based intravenous treatment of CNS diseases imply BBB transport success (I saw a reference that suggested it did, but my lay reading sees not...read more
3 stars

RE:RE:Alzheimer’s ?

I was thinking similar things, jawcellis. Glen Campbell, who is now at an advanced stage of the disease, was in the news recently. The NBC article below about him has a link to his last recording...read more
5 stars

RE:Alzheimer’s ?

I wish for my Father who is 86 that we could speed things up.  He has dementia now and will get worse.  We all fear Altzhimer's disease.  Thank you BIOasis .  rate and reply
3 stars

RE:Alzheimer’s ?

Thanks for posting that, KayakerBC. I had never seen that before. It's quite recent, too, having been released in August. I guess I'm safe in commenting about this because the MedImmune program with...read more
2.5 stars

Alzheimer’s ?

In the BTI March 17 news release, Dr. Carl Webster is mentioned (Associate Director, Antibody Discovery and Protein Engineering, MedImmune.) MARCH 17th, 2014 – BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF;...read more
2 stars

RE:Shire & Abbvie

Inversion Implosion: AbbVie-Shire Merger Officially Dead Nathan Vardi Nathan Vardi Forbes Staff After the government revised the rules about inversion deals, the proposed $54 billion merger between...read more
3 stars

RE:RE:Shopping

This ia a different set of circumsaltances alltogether....abbvie and shire left aquisitionless....shire with 1.63billion in free cash from abbvie.....and abbvie who just saved in the neighborhood of...read more
2.5 stars

RE:Shopping

Wholly expected, KayakerBC. Not only does it make sense for Shire to go shopping but their LSD programs will be threatened by biOasis if Scarpa's animal study is successful.     Because B4B is a...read more
2.5 stars

RE:RE:RE:Lioslios Group

Inchbury, I understand your interest in American-style business development but Willow Tree gives us that and more. Their "back room" has capabilities that are essential for a platform technology like...read more
2.5 stars

RE:RE:RE:Lioslios Group

inchbury, you're about 5 to 6 months behind the times. liolios is no longer representing bti, gale capital is as of june 16th. willow tree capital is now representing the company's business...read more

How to invest in private equity without writing a $1 million check.

Click here to watch the video